Search for: "SINORGCHEM V ITC" Results 1 - 10 of 10
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Dec 2007, 9:33 pm
Cir. 2007, 06-1633) On appeal to the CAFC, Sinorgchem argued that a limited exclusion order  by the International Trade Commission ("ITC")  and decision that  Sinorgchem infringed four method claims of Flexys America’s  U.S. [read post]
4 Jan 2008, 11:10 am
Flexsys has issued a press release responding to the CAFC's recent  decision regarding the patent infringement suit with Sinorgchem. [read post]
23 Dec 2007, 12:30 pm
By a 2-1 vote, the CAFC reversed the ITC on a claim construction issue ("controlled amount"), vacated, and remanded.Flexsys, the patent holder, went after Sinorgchem. [read post]
28 Aug 2010, 1:00 am
ITC and General Protecht Group and Wenzhou Trimone and Shanghai Ele (2009-1338, -1369) precedential General Protecht Group and Wenzhou Trimone and Shanghai Ele v. [read post]
13 Mar 2009, 4:00 am
(Securing Innovation) PriorSmart.com search tool, tracking patent documents (Competitive Info) (Patently-O) Patent damages as an incentive to transact (IP finance) IPscore, new patent evaluation toy (IP finance) Patent portfolios can pull companies out of financial rut (Law360)   Global - Copyright Expanding the public domain: part zero (Creative Commons)     Australia Pioneering decision on non-use: Pioneer Computers Australia Pty Limited v Pioneer KK (Australian… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]